Memorial Sloan Kettering Cancer Center
Lecture Summary - ASCO 2022 Updated Interim Analysis of the Randomized Phase 1b/3 Study of Tazemetostat in Combination With Lenalidomide & Rituximab in R/R FL
By
ASCO 2022 Conference Coverage
FEATURING
Connie Lee Batlevi
By
ASCO 2022 Conference Coverage
FEATURING
Connie Lee Batlevi
Login to view comments.
Click here to Login